272 related articles for article (PubMed ID: 29034767)
1. In Search of a Converging Cellular Mechanism in Nanotoxicology and Nanomedicine in the Treatment of Cancer.
Gulumian M; Andraos C
Toxicol Pathol; 2018 Jan; 46(1):4-13. PubMed ID: 29034767
[TBL] [Abstract][Full Text] [Related]
2. Pro-Death or Pro-Survival: Contrasting Paradigms on Nanomaterial-Induced Autophagy and Exploitations for Cancer Therapy.
Zhang Y; Zhang L; Gao J; Wen L
Acc Chem Res; 2019 Nov; 52(11):3164-3176. PubMed ID: 31621285
[TBL] [Abstract][Full Text] [Related]
3. Nanomaterial designing strategies related to cell lysosome and their biomedical applications: A review.
Rathore B; Sunwoo K; Jangili P; Kim J; Kim JH; Huang M; Xiong J; Sharma A; Yang Z; Qu J; Kim JS
Biomaterials; 2019 Aug; 211():25-47. PubMed ID: 31078050
[TBL] [Abstract][Full Text] [Related]
4. Editorial: Nanotoxicology and Nanomedicine: A special issue of the Food and Chemical Toxicology.
Sahu SC
Food Chem Toxicol; 2015 Nov; 85():1. PubMed ID: 26248127
[No Abstract] [Full Text] [Related]
5. Nanotoxicology and nanomedicine: making hard decisions.
Linkov I; Satterstrom FK; Corey LM
Nanomedicine; 2008 Jun; 4(2):167-71. PubMed ID: 18329962
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicine and nanotoxicology: two sides of the same coin.
Kagan VE; Bayir H; Shvedova AA
Nanomedicine; 2005 Dec; 1(4):313-6. PubMed ID: 17292104
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulating Nanomedicine for Cancer Therapy.
Liu Z; Jiang W; Nam J; Moon JJ; Kim BYS
Nano Lett; 2018 Nov; 18(11):6655-6659. PubMed ID: 30185039
[TBL] [Abstract][Full Text] [Related]
8. Nanomedicine and nanotoxicology: the pros and cons for neurodegeneration and brain cancer.
Catalan-Figueroa J; Palma-Florez S; Alvarez G; Fritz HF; Jara MO; Morales JO
Nanomedicine (Lond); 2016 Jan; 11(2):171-87. PubMed ID: 26653284
[TBL] [Abstract][Full Text] [Related]
9. Involvement of planned cell death of necroptosis in cancer treatment by nanomaterials: Recent advances and future perspectives.
Sharifi M; Hosseinali SH; Saboury AA; Szegezdi E; Falahati M
J Control Release; 2019 Apr; 299():121-137. PubMed ID: 30763621
[TBL] [Abstract][Full Text] [Related]
10. Toxicity assessment of nanomaterials: methods and challenges.
Dhawan A; Sharma V
Anal Bioanal Chem; 2010 Sep; 398(2):589-605. PubMed ID: 20652549
[TBL] [Abstract][Full Text] [Related]
11. Nanomaterial applications in multiple sclerosis inflamed brain.
Ballerini C; Baldi G; Aldinucci A; Maggi P
J Neuroimmune Pharmacol; 2015 Mar; 10(1):1-13. PubMed ID: 25616566
[TBL] [Abstract][Full Text] [Related]
12. Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity.
Stern ST; Adiseshaiah PP; Crist RM
Part Fibre Toxicol; 2012 Jun; 9():20. PubMed ID: 22697169
[TBL] [Abstract][Full Text] [Related]
13. Nanomaterials for Nanotheranostics: Tuning Their Properties According to Disease Needs.
Wong XY; Sena-Torralba A; Álvarez-Diduk R; Muthoosamy K; Merkoçi A
ACS Nano; 2020 Mar; 14(3):2585-2627. PubMed ID: 32031781
[TBL] [Abstract][Full Text] [Related]
14. Nanomaterial-induced autophagy: a new reversal MDR tool in cancer therapy?
Panzarini E; Dini L
Mol Pharm; 2014 Aug; 11(8):2527-38. PubMed ID: 24921216
[TBL] [Abstract][Full Text] [Related]
15. Biomedical Applications of Nanomaterials as Therapeutics.
Ng CT; Baeg GH; Yu LE; Ong CN; Bay BH
Curr Med Chem; 2018; 25(12):1409-1419. PubMed ID: 28393698
[TBL] [Abstract][Full Text] [Related]
16. Intracellular and extracellular targets as mechanisms of cancer therapy by nanomaterials in relation to their physicochemical properties.
Andraos C; Gulumian M
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Mar; 13(2):e1680. PubMed ID: 33111484
[TBL] [Abstract][Full Text] [Related]
17. The redox-active nanomaterial toolbox for cancer therapy.
Ibañez IL; Notcovich C; Catalano PN; Bellino MG; Durán H
Cancer Lett; 2015 Apr; 359(1):9-19. PubMed ID: 25597786
[TBL] [Abstract][Full Text] [Related]
18. No king without a crown--impact of the nanomaterial-protein corona on nanobiomedicine.
Docter D; Strieth S; Westmeier D; Hayden O; Gao M; Knauer SK; Stauber RH
Nanomedicine (Lond); 2015 Feb; 10(3):503-19. PubMed ID: 25707981
[TBL] [Abstract][Full Text] [Related]
19. Molecular and cellular cues governing nanomaterial-mucosae interactions: from nanomedicine to nanotoxicology.
das Neves J; Sverdlov Arzi R; Sosnik A
Chem Soc Rev; 2020 Jul; 49(14):5058-5100. PubMed ID: 32538405
[TBL] [Abstract][Full Text] [Related]
20. Nanomaterial-modulated autophagy: underlying mechanisms and functional consequences.
Zheng W; Wei M; Li S; Le W
Nanomedicine (Lond); 2016 Jun; 11(11):1417-30. PubMed ID: 27193191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
